TR-64

N/A

Report date: 2022/11/07 15:30:21
NME

Base Information

Drug NameTR-64
Drug Alias NameTR64片TR-64
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionStem cell growth factor receptor inhibitors
TargetsStem cell growth factor receptor
Therapy Area/IndicationsSolid tumoursGastrointestinal Stromal Tumors
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesTarapeutics Science Inc
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesTarapeutics Science Inc
Inactive CompaniesN/A
Active IndicationsSolid tumoursGastrointestinal Stromal Tumors
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A